{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:41:33Z","timestamp":1784673693253,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare the late toxicity rates after two different high dose rate (HDR) adjuvant intravaginal interventional radiotherapy (IRT-brachytherapy) dose schedules in stage I-II endometrial cancer.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Stage I-II patients with endometrial cancer treated with surgery (with or without lymphadenectomy) and adjuvant HDR-IRT between 2014 and 2020 were included in this analysis. Patients were treated with two schedules. In the first cohort (C1), 21\u00a0Gy were delivered in three weekly fractions (7\u00a0Gy) prescribed 0.5\u00a0cm from the applicator surface. In the second cohort (C2), 24\u00a0Gy were delivered in four weekly fractions (6\u00a0Gy). The clinical target volume was the upper third of the vagina for C1 and the upper 3\u00a0cm for C2. HDR-IRT technique and point prescription (5\u00a0mm depth from the applicator surface) were the same for all patients. Vaginal toxicity was scored according to the CTCAE 5.0 scale in terms of the presence <jats:italic>versus<\/jats:italic> absence of any toxicity grade. The correlation among toxicity and clinical covariates (age, lymphadenectomy, fractionation, stage) was tested by Pearson correlation test (univariate) and by logistic regression (multivariable).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>114 stage I and three stage II patients, median age 62 (range: 32\u201385) years, were included in this analysis. The mean follow-up was 56.3\u00a0months in C1 (40\u201376) and 20\u00a0months in C2 (8\u201342). Vaginal late toxicity was recorded in 40 and 15 patients in C1 and 2, respectively. Age, lymphadenectomy, and fractionation were significantly correlated with toxicity at univariate analysis (p value\u2009=\u20090.029, 0.006, and 0.002, respectively), while stepwise logistic regression confirmed only age and fractionation as significantly correlated parameters (p value\u2009=\u20090.02 and 0.001, respectively). Three-year local relapse-free, distant metastasis-free and cause-specific survival rates were 96.6%, 94.8%, and 99.1%, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This analysis showed lower vaginal late toxicity rate in C2 compared to C1.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11547-022-01455-y","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T05:02:38Z","timestamp":1643432558000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates"],"prefix":"10.1007","volume":"127","author":[{"given":"Valentina","family":"Lancellotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-201X","authenticated-orcid":false,"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dinapoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Campitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Nardangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fionda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Cas\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Cornacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Giuseppe","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"1455_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0020-7292(12)60024-1","volume":"119","author":"F Amant","year":"2012","unstructured":"Amant F, Mansoor RM, Creutzberg CL (2012) Cancer of the corpus uteri. Int J Gynaecol Obstet 119:110\u2013117. https:\/\/doi.org\/10.1016\/S0020-7292(12)60024-1","journal-title":"Int J Gynaecol Obstet"},{"key":"1455_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1634\/theoncologist.2013-0475","volume":"19","author":"NA Latif","year":"2014","unstructured":"Latif NA, Haggerty A, Jean S et al (2014) Adjuvant therapy in early-stage endometrial cancer: a systematic review of the evidence, guidelines, and clinical practice in the U S. Oncologist 19:645\u2013653. https:\/\/doi.org\/10.1634\/theoncologist.2013-0475","journal-title":"Oncologist"},{"key":"1455_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/s0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WLJ, Koper PCM et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma. Lancet 355:1404\u20131411. https:\/\/doi.org\/10.1016\/s0140-6736(00)02139-5","journal-title":"Lancet"},{"key":"1455_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744\u2013751. https:\/\/doi.org\/10.1016\/j.ygyno.2003.11.048","journal-title":"Gynecol Oncol"},{"key":"1455_CR5","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1002\/cncr.30228","volume":"122","author":"StrohlAE RydzewskiNR","year":"2016","unstructured":"RydzewskiNR StrohlAE, Donnelly ED et al (2016) Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: a National Cancer Data Base study. Cancer 122:3724\u20133731. https:\/\/doi.org\/10.1002\/cncr.30228","journal-title":"Cancer"},{"key":"1455_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, noninferiority, randomised trial. Lancet 375:816\u2013823. https:\/\/doi.org\/10.1016\/S0140-6736(09)62163-2","journal-title":"Lancet"},{"key":"1455_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, MatiasQuiu X, Vergote I et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31:12\u201339. https:\/\/doi.org\/10.1136\/ijgc-2020-002230","journal-title":"Int J Gynecol Cancer"},{"key":"1455_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","volume":"15","author":"MM Harkenrider","year":"2016","unstructured":"Harkenrider MM, Grover S, Erickson BA et al (2016) Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society. Brachytherapy 15:23\u201329. https:\/\/doi.org\/10.1016\/j.brachy.2015.09.012","journal-title":"Brachytherapy"},{"key":"1455_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","volume":"16","author":"MM Harkenrider","year":"2017","unstructured":"Harkenrider MM, Block AM, Alektiar KM et al (2017) American Brachytherapy Task Group Report: adjuvant vaginal brachytherapy for early-stage endometrial cancer: a comprehensive review. Brachytherapy 16:95\u2013108. https:\/\/doi.org\/10.1016\/j.brachy.2016.04.005","journal-title":"Brachytherapy"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","volume":"11","author":"W Small Jr","year":"2012","unstructured":"Small W Jr, Beriwal S, Demanes DJ et al (2012) American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 11:58\u201367. https:\/\/doi.org\/10.1016\/j.brachy.2011.08.005","journal-title":"Brachytherapy"},{"key":"1455_CR11","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/(sici)1097-0258(19971130)16:22<2529::aid-sim692>3.0.co;2-j","volume":"16","author":"AJ Sankoh","year":"1997","unstructured":"Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16:2529\u20132542. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19971130)16:22%3c2529::aid-sim692%3e3.0.co;2-j","journal-title":"Stat Med"},{"key":"1455_CR12","doi-asserted-by":"publisher","DOI":"10.2427\/5845","author":"V Valentini","year":"2008","unstructured":"Valentini V, Maurizi F, Tagliaferri L et al (2008) Spider: managing clinical data of cancer patients treated through a multidisci-plinary approach by a palm-based system. Ital J Public Health JPH. https:\/\/doi.org\/10.2427\/5845","journal-title":"Ital J Public Health JPH"},{"issue":"15","key":"1455_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12094-012-0893-0","volume":"2013","author":"A Rovirosa","year":"2013","unstructured":"Rovirosa A, Valduvieco I, Ascaso C et al (2013) Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma. ClinTrans Oncol 2013(15):111\u2013116. https:\/\/doi.org\/10.1007\/s12094-012-0893-0","journal-title":"ClinTrans Oncol"},{"key":"1455_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.brachy.2017.07.003","volume":"16","author":"A Rovirosa","year":"2017","unstructured":"Rovirosa A, Herreros A, Camacho C et al (2017) Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma. Brachytherapy 16:1169\u20131174. https:\/\/doi.org\/10.1016\/j.brachy.2017.07.003","journal-title":"Brachytherapy"},{"key":"1455_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.brachy.2008.01.001","volume":"7","author":"I Chong","year":"2008","unstructured":"Chong I, Hoskin PJ (2008) Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer. Brachytherapy 7:195\u2013199. https:\/\/doi.org\/10.1016\/j.brachy.2008.01.001","journal-title":"Brachytherapy"},{"key":"1455_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12094-012-0974-0","volume":"15","author":"I Valduvieco","year":"2013","unstructured":"Valduvieco I, Rovirosa A, Herreros A et al (2013) Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity. Clin Trans Oncol 15:602\u2013607. https:\/\/doi.org\/10.1007\/s12094-012-0974-0","journal-title":"Clin Trans Oncol"},{"key":"1455_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.brachy.2015.10.010","volume":"15","author":"E Perrucci","year":"2016","unstructured":"Perrucci E, Lancellotta V, Bini V et al (2016) Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage IeII endometrial cancer: a monoinstitutional experience. Brachytherapy 15:177\u2013184. https:\/\/doi.org\/10.1016\/j.brachy.2015.10.010","journal-title":"Brachytherapy"},{"key":"1455_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5114\/jcb.2018.77953","volume":"10","author":"R Autorino","year":"2018","unstructured":"Autorino R, Tagliaferri L, Campitelli M et al (2018) EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis. J Contemp Brachytherapy 10:315\u2013320. https:\/\/doi.org\/10.5114\/jcb.2018.77953","journal-title":"J Contemp Brachytherapy"},{"key":"1455_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.brachy.2019.08.007","volume":"18","author":"CL Guy","year":"2019","unstructured":"Guy CL, Fields EC, Quinn BA et al (2019) The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation. Brachytherapy 18:763\u2013770. https:\/\/doi.org\/10.1016\/j.brachy.2019.08.007","journal-title":"Brachytherapy"},{"key":"1455_CR20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","volume":"62","author":"B Sorbe","year":"2005","unstructured":"Sorbe B, Straumits A, Karlsso L (2005) Intravaginal high-dose-rate brachytherapy for Stage I endometrial cancer: A randomized study of two dose-per-fraction levels. Int J Radiat Oncol Biol Phys 62:1385\u20131389. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.079","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1455_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12094-015-1463-z","volume":"18","author":"I R\u00edos","year":"2016","unstructured":"R\u00edos I, Rovirosa A, Ascaso C et al (2016) Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients. ClinTrans Oncol 18:925\u2013930. https:\/\/doi.org\/10.1007\/s12094-015-1463-z","journal-title":"ClinTrans Oncol"},{"key":"1455_CR22","doi-asserted-by":"publisher","first-page":"20120428","DOI":"10.1259\/bjr.20120428","volume":"86","author":"P Humprey","year":"2013","unstructured":"Humprey P, Cornes P, Al-Booz H (2013) Vaginal vault brachytherapy in endometrial cancer: verifying target coverage with image-guided applicator placement. Br J Radiol 86:20120428. https:\/\/doi.org\/10.1259\/bjr.20120428","journal-title":"Br J Radiol"},{"key":"1455_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","volume":"82","author":"AY Bahng","year":"2012","unstructured":"Bahng AY, Dagan A, Bruner DW, Lin LL (2012) Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 82:667\u2013673. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.071","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1455_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.brachy.2019.03.001","volume":"18","author":"BJ Ager","year":"2019","unstructured":"Ager BJ, Francis SR, Do OA et al (2019) Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer? Brachytherapy 18:453\u2013461. https:\/\/doi.org\/10.1016\/j.brachy.2019.03.001","journal-title":"Brachytherapy"},{"key":"1455_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ygyno.2017.08.005","volume":"147","author":"A Torgeson","year":"2017","unstructured":"Torgeson A, Boothe D, Poppe MM et al (2017) Disparities in care for elderly women with endometrial cancer adversely effects survival. Gynecol Oncol 147:320\u2013328. https:\/\/doi.org\/10.1016\/j.ygyno.2017.08.005","journal-title":"Gynecol Oncol"},{"key":"1455_CR26","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/cncr.22997","volume":"110","author":"CM Lee","year":"2007","unstructured":"Lee CM, Szabo A, Shrieve DC et al (2007) Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study. Cancer 110:2092\u20132100. https:\/\/doi.org\/10.1002\/cncr.22997","journal-title":"Cancer"},{"key":"1455_CR27","doi-asserted-by":"publisher","first-page":"2178469","DOI":"10.1155\/2018\/2178469","volume":"2018","author":"V Lancellotta","year":"2018","unstructured":"Lancellotta V, Kov\u00e1cs G, Tagliaferri L et al (2018) Age is not a limiting factor in interventional radiotherapy (brachytherapy) for patients with localized cancer. Biomed Res Int 2018:2178469. https:\/\/doi.org\/10.1155\/2018\/2178469","journal-title":"Biomed Res Int"},{"key":"1455_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5114\/jcb.2018.76981","volume":"10","author":"R Autorino","year":"2018","unstructured":"Autorino R, Vicenzi L, Tagliaferri L et al (2018) A national survey of AIRO (Italian Association of Radiation Oncology) brachytherapy (Interventional Radiotherapy) study group. J Contemp Brachytherapy 10:254\u2013259. https:\/\/doi.org\/10.5114\/jcb.2018.76981","journal-title":"J Contemp Brachytherapy"},{"key":"1455_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejso.2011.12.001","volume":"38","author":"G Ferrandina","year":"2012","unstructured":"Ferrandina G, Lucidi A, Paglia A et al (2012) Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. Eur J Surg Oncol 38:238\u2013244. https:\/\/doi.org\/10.1016\/j.ejso.2011.12.001","journal-title":"Eur J Surg Oncol"},{"key":"1455_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5114\/jcb.2019.83137","volume":"11","author":"L Tagliaferri","year":"2019","unstructured":"Tagliaferri L, Kov\u00e1cs G, Aristei C et al (2019) Current state of interventional radiotherapy (brachytherapy) education in Italy: Results of the INTERACTS survey. J Contemp Brachytherapy 11:48\u201353. https:\/\/doi.org\/10.5114\/jcb.2019.83137","journal-title":"J Contemp Brachytherapy"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-022-01455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-022-01455-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-022-01455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:43:04Z","timestamp":1648489384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-022-01455-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s11547-022-01455-y","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Ethical approval was waived by the local Ethics Committee of University A. Gemelli in view of the retrospective nature of the study, and all the procedures being performed were part of the routine care.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}